Medical Microinstruments (MMI) raised $125 million in Series D financing to broaden deployment of its Symani Surgical System and explore new microsurgery applications, including an experimental approach for Alzheimer’s disease. The round is designed to scale a robotic microsurgery platform while supporting translational work beyond its current focus areas.